Sasha Stiles turned GPT-2 experiments into a self-writing poem at a Museum of Modern Art installation—and a new way to think about text-generating AI optimization ...
Extracting and analyzing relevant medical information from large-scale databases such as biobanks poses considerable challenges. To exploit such "big data," attempts have focused on large sampling ...
A 15-second clip created by an artificial intelligence tool owned by the Chinese technology company ByteDance appears more ...
Joseph Yracheta was in charge of a repository that compiled and protected tribal health data. Then its funding was cut. Credit...Tara Weston for The New York Times Supported by Lost Science is an ...
The Trump administration’s move to give deportation officials access to Medicaid data is putting hospitals and states in a bind as they weigh whether to alert immigrant patients that their personal ...
Start reading recent internet conversations about AI, and you'll find an anecdote that surfaces with increasing frequency: ChatGPT delivered lifesaving medical advice. "Three weeks ago I woke up from ...
AstraZeneca’s Dr. Sophie Kirschner to present data demonstrating how biomodal’s 6‑base sequencing solution enhances the sensitivity of liquid biopsy biomodal, an omics-based life sciences technology ...
People who interact with chatbots for emotional support or other personal reasons are likelier to report symptoms of depression or anxiety, a new study finds. The researchers from Mass General Brigham ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...
Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...
Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data is essential for moving from AI experiments to measurable results. In ...
Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...